Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

6.95USD
22 Sep 2017
Change (% chg)

$0.03 (+0.36%)
Prev Close
$6.92
Open
$6.94
Day's High
$7.00
Day's Low
$6.90
Volume
1,987
Avg. Vol
7,058
52-wk High
$8.34
52-wk Low
$4.16

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 23 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.44 2.44 2.44 2.44

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 7 18.04 19.26 14.14 18.12
Quarter Ending Dec-17 7 22.32 23.56 19.14 27.20
Year Ending Dec-17 8 69.22 74.37 65.57 58.63
Year Ending Dec-18 8 138.70 185.70 105.79 135.14
Earnings (per share)
Quarter Ending Sep-17 7 -0.18 -0.15 -0.20 -0.09
Quarter Ending Dec-17 7 -0.16 -0.12 -0.18 -0.04
Year Ending Dec-17 7 -1.23 -0.70 -1.36 -0.49
Year Ending Dec-18 7 -0.32 -0.25 -0.39 -0.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 14.51 15.14 0.63 4.34
Quarter Ending Mar-17 10.29 11.82 1.53 14.88
Quarter Ending Dec-16 8.41 9.53 1.12 13.30
Quarter Ending Sep-16 5.45 6.34 0.89 16.33
Quarter Ending Jun-16 8.57 9.29 0.72 8.35
Earnings (per share)
Quarter Ending Jun-17 -0.18 -0.77 0.59 -324.71
Quarter Ending Mar-17 -0.20 -0.21 0.01 -3.86
Quarter Ending Dec-16 -0.25 -0.32 0.07 -28.00
Quarter Ending Sep-16 -0.20 -0.39 0.19 -91.83
Quarter Ending Jun-16 -0.28 -0.42 0.14 -52.73

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 18.04 18.04 17.83 17.67 18.12
Quarter Ending Dec-17 22.32 22.32 21.94 20.71 27.20
Year Ending Dec-17 69.22 69.22 68.61 64.88 58.63
Year Ending Dec-18 138.70 138.70 138.70 129.02 135.14
Earnings (per share)
Quarter Ending Sep-17 -0.18 -0.18 -0.18 -0.16 -0.09
Quarter Ending Dec-17 -0.16 -0.16 -0.16 -0.14 -0.04
Year Ending Dec-17 -1.23 -1.23 -1.23 -0.69 -0.49
Year Ending Dec-18 -0.32 -0.32 -0.32 -0.23 -0.03

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 1 0
Quarter Ending Dec-17 0 0 1 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0